Transgender Persons

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Transgender Persons is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

0/100

Attrition Rate

50/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

2

clinical trials

Terminated1 · 50%

Recruiting1 · 50%

Clinical Trials

Trial Activity

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Terminated·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00865566·2,504 enrolled

Research Participation With Transgender and Gender-Diverse Youth

Recruiting·VVirginia Commonwealth University·N/A·NCT05927350·250 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)